Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Labstyle Innovat (DRIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,127
  • Shares Outstanding, K 21,340
  • Annual Sales, $ 5,170 K
  • Annual Income, $ -15,740 K
  • 36-Month Beta -2.00
  • Price/Sales 4.13
  • Price/Cash Flow N/A
  • Price/Book 4.03
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.05
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.43
  • Growth Rate Est. (year over year) +232,425.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.89 +11.24%
on 08/22/18
1.38 -28.26%
on 08/27/18
-0.05 (-4.81%)
since 08/17/18
3-Month
0.89 +11.24%
on 08/22/18
1.55 -36.13%
on 06/22/18
-0.43 (-30.28%)
since 06/18/18
52-Week
0.89 +11.24%
on 08/22/18
3.64 -72.80%
on 10/18/17
-0.78 (-44.07%)
since 09/18/17

Most Recent Stories

More News
DarioHealth Chosen by Attain Health for Pilot Study to Improve Cystic Fibrosis Related Diabetes Management

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has entered into an agreement with Attain Health, a provider of integrative...

DRIO : 0.99 (-1.00%)
DarioHealth to Exhibit at American Association of Diabetes Educators Conference on August 17-20 in Baltimore

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it will exhibit the DarioEngage platform and its other digital health...

DRIO : 0.99 (-1.00%)
DarioHealth Reports Second Quarter 2018 Results

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the second quarter ended June 30,...

DRIO : 0.99 (-1.00%)
DarioHealth Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 9, 2018 / DarioHealth Corp. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 9:00 AM Eastern Time.

DRIO : 0.99 (-1.00%)
DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its second quarter 2018 results on Thursday, August...

DRIO : 0.99 (-1.00%)
DarioHealth Launches New Annual Membership & Product Enhancements to Promote Long-Term Use, Higher Levels of User Engagement, and Associated Sustainable Behavioral Changes

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that following new data presented at the American Diabetes Association...

DRIO : 0.99 (-1.00%)
DarioHealth CEO Erez Raphael's Interview Published in Research 2 Guidance

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Research2Guidance, an analyst and strategic consulting company...

DRIO : 0.99 (-1.00%)
DarioHealth Appoints Healthcare Technology Entrepreneur and Venture Capital Partner Yoav Shaked as Chairman of the Board

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today Yoav Shaked has joined the Company as Chairman of the Board. The Company's...

DRIO : 0.99 (-1.00%)
DarioHealth Presents New Data at American Diabetes Association's 78th Scientific Sessions on June 25, 2018

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported new data at the American Diabetes Association's (ADA) 78th Scientific...

DRIO : 0.99 (-1.00%)
DarioHealth to Deliver Three Poster Presentations With New Data at American Diabetes Association on June 25, 2018

NEW YORK and CAESAREA, Israel, June 21, 2018 DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced JC Muyl, the Company's...

DRIO : 0.99 (-1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade DRIO with:

Business Summary

DarioHealth Corp. creates mobile and digital tools. The company's product the Dario(TM) Smart Diabetes Management Solution, is a platform for diabetes management which combines blood glucose meter, native smart phone app, website portal and treatment tools to users living with diabetes, their doctors...

See More

Key Turning Points

2nd Resistance Point 1.02
1st Resistance Point 1.01
Last Price 0.99
1st Support Level 0.97
2nd Support Level 0.94

See More

52-Week High 3.64
Fibonacci 61.8% 2.59
Fibonacci 50% 2.27
Fibonacci 38.2% 1.94
Last Price 0.99
52-Week Low 0.89

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar